521985-24-0 Usage
Uses
Used in Pharmaceutical Industry:
1-Methyl-1H-pyrrolo[2,3-b]pyridin-3-yl-3-boronic acid is used as a synthetic intermediate for the development of new pharmaceuticals. Its strong interaction with proteins or enzymes via the boronic acid group allows for the creation of compounds with potential therapeutic applications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-Methyl-1H-pyrrolo[2,3-b]pyridin-3-yl-3-boronic acid is used as a key component in the design and synthesis of novel therapeutic substances. Its unique physiochemical properties make it a valuable asset in the search for new drugs and treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 521985-24-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,2,1,9,8 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 521985-24:
(8*5)+(7*2)+(6*1)+(5*9)+(4*8)+(3*5)+(2*2)+(1*4)=160
160 % 10 = 0
So 521985-24-0 is a valid CAS Registry Number.
521985-24-0Relevant academic research and scientific papers
AMIDE DERIVATIVES AND DRUGS
-
Page 20, (2010/02/08)
The present invention provides an amide derivative represented by the following formula [1]: wherein n represents 0 or 1; X represents CR4 or N; Y represents CR6 or N; Z represents CR7 or N; R1 and R2 may be the same or different and each represents hydrogen, optionally substituted alkyl, acyl, optionally substituted aryl, or an optionally substituted aromatic heterocyclic group; R4, R5, R6 and R7 may be the same or different and each represents hydrogen, halogen, hydroxy, amino, alkyl, haloalkyl, alkoxy, monoalkylamino, dialkylamino, arylalkyl, cyano, or nitro; and R3 represents optionally substituted alkylamino, optionally substituted arylamino, or optionally substituted cyclic amino, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising them as an active ingredient. The compound of the present invention is useful as a TGF-β inhibitor.
